Concepedia
Statistics
Publications
11
Citations
606
H-Index
Active since
2000
Affiliations
Spark Therapeutics (United States)(Current)
Ark Therapeutic (United States)
Cornell University
Kindai University
Dana-Farber Cancer Institute
Vijaya G. Tirunagaru is an author at Spark Therapeutics (United States) specializing in oncology, molecular oncology, and medicine.
Publications per year
2000–2023
A strategy to identify positional candidate genes conferring Marek’s disease resistance by integrating DNA microarrays and genetic mapping
H.‐C. Liu, Hans H. Cheng, Vijaya G. Tirunagaru et al. · Animal Genetics · 2001 · 140 citations
Agriculture, Genetics, Poultry Science +13
An Expressed Sequence Tag Database of T-Cell-Enriched Activated Chicken Splenocytes: Sequence Analysis of 5251 Clones
Vijaya G. Tirunagaru, Luc Sofer, Jing Cui et al. · Genomics · 2000 · 103 citations
Life Sciences, Bioinformatics, Immunology +12
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or Lymphomas
Mrinal M. Gounder, Todd M. Bauer, Gary K. Schwartz et al. · Journal of Clinical Oncology · 2023 · 91 citations · Full text
Medicine, Oncology, Pharmacology +12
Tarloxotinib Is a Hypoxia-Activated Pan-HER Kinase Inhibitor Active Against a Broad Range of HER-Family Oncogenes
Adriana Estrada‐Bernal, Anh T. Le, Andrea E. Doak et al. · Clinical Cancer Research · 2020 · 81 citations · Full text
Medicine, Oncology, Pharmacology +17
Whole-mount analysis reveals normal numbers of dopaminergic neurons following misexpression of?-Synuclein inDrosophila
Yakov Pesah, Heather Burgess, Brooke W. Middlebrooks et al. · genesis · 2005 · 78 citations
Life Sciences, Neurobiology, Neuroscience +17
1–5 of 11